|
HRMY
|
Harmony Biosciences Holdings, Inc.
|
1.68%
|
US
|
NASDAQ
|
|
VTYX
|
Ventyx Biosciences, Inc.
|
1.59%
|
US
|
NASDAQ
|
|
ARVN
|
Arvinas, Inc.
|
1.54%
|
US
|
NASDAQ
|
|
PBH
|
Prestige Brand Holdings, Inc.
|
1.50%
|
US
|
NYSE
|
|
SUPN
|
Supernus Pharmaceuticals, Inc.
|
1.48%
|
US
|
NASDAQ
|
|
CORT
|
Corcept Therapeutics Incorporated
|
1.43%
|
US
|
NASDAQ
|
|
SIGA
|
SIGA Technologies Inc.
|
1.42%
|
US
|
NASDAQ
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
1.42%
|
US
|
NASDAQ
|
|
ESPR
|
Esperion Therapeutics, Inc.
|
1.13%
|
US
|
NASDAQ
|
|
PLRX
|
Pliant Therapeutics, Inc.
|
0.93%
|
US
|
NASDAQ
|
|
PRVB
|
Provention Bio, Inc.
|
0.81%
|
US
|
NASDAQ
|
|
INVA
|
Innoviva, Inc.
|
0.77%
|
US
|
NASDAQ
|
|
TBPH
|
Theravance Biopharma, Inc.
|
0.75%
|
US
|
NASDAQ
|
|
AMPH
|
Amphastar Pharmaceuticals, Inc.
|
0.69%
|
US
|
NASDAQ
|
|
ACRS
|
Aclaris Therapeutics, Inc.
|
0.60%
|
US
|
NASDAQ
|
|
COLL
|
Collegium Pharmaceutical, Inc.
|
0.55%
|
US
|
NASDAQ
|
|
NKTR
|
Nektar Therapeutics
|
0.48%
|
US
|
NASDAQ
|
|
CARA
|
Cara Therapeutics, Inc.
|
0.31%
|
US
|
NASDAQ
|
|
ANIP
|
ANI Pharmaceuticals, Inc.
|
0.24%
|
US
|
NASDAQ
|